Tau hyperphosphorylation induces oligomeric insulin accumulation and insulin resistance in neurons

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Brain : a journal of neurology

• Publication date

  2017-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/brain/awx256PMID 29053786
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Exosomal biomarkers of brain insulin resistance associated with regional atrophy in Alzheimer's disease

  2017cited by this paper
• Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease.

  2017cited by this paper
• Astrocytic Insulin Signaling Couples Brain Glucose Uptake with Nutrient Availability.

  2016cited by this paper
• The Role of the Carboxyl-Terminal Sequence of Tau and MAP2 in the Pathogenesis of Dementia

  2016cited by this paper
• RNA Interference Silencing of Glycogen Synthase Kinase 3β Inhibites Tau Phosphorylation in Mice with Alzheimer Disease

  2016cited by this paper
• Imaging cellular structures in super-resolution with SIM, STED and Localisation Microscopy: A practical comparison

  2016cited by this paper
• Structure, Aggregation, and Activity of a Covalent Insulin Dimer Formed During Storage of Neutral Formulation of Human Insulin.

  2016cited by this paper
• Localized insulin amyloidosis with use of concentrated insulin: a potential complication

  2016cited by this paper
• Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease.

  2016cited by this paper
• Intracerebroventricular administration of okadaic acid induces hippocampal glucose uptake dysfunction and tau phosphorylation.

  2016cited by this paper
• Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease.

  2015cited by this paper
• Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural‐derived blood exosomes of preclinical Alzheimer's disease

  2015cited by this paper
• Super-resolution Microscopy in Plant Cell Imaging.

  2015cited by this paper
• Insulin resistance predicts brain amyloid deposition in late middle‐aged adults

  2015cited by this paper
• Insulin Resistance Prevents AMPK-induced Tau Dephosphorylation through Akt-mediated Increase in AMPKSer-485 Phosphorylation*

  2015cited by this paper
• O-GlcNAc and neurodegeneration: biochemical mechanisms and potential roles in Alzheimer's disease and beyond.

  2014cited by this paper
• Short-Term High-Fat-and-Fructose Feeding Produces Insulin Signaling Alterations Accompanied by Neurite and Synaptic Reduction and Astroglial Activation in the Rat Hippocampus

  2014cited by this paper
• Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer’s disease and tauopathies

  2014cited by this paper
• GABAergic Neurogliaform Cells Represent Local Sources of Insulin in the Cerebral Cortex

  2014influential reference
• Alterations in the Nuclear Architecture Produced by the Overexpression of Tau Protein in Neuroblastoma Cells

  2013cited by this paper
• CSF and Brain Indices of Insulin Resistance, Oxidative Stress and Neuro-Inflammation in Early versus Late Alzheimer’s Disease

  2013cited by this paper
• Nonautonomous regulation of neuronal migration by insulin signaling, DAF-16/FOXO, and PAK-1.

  2013cited by this paper
• The Pathogenic Aβ43 Is Enriched in Familial and Sporadic Alzheimer Disease

  2013cited by this paper
• Insulin has multiple antiamyloidogenic effects on human neuronal cells.

  2013cited by this paper
• High-molecular weight Aβ oligomers and protofibrils are the predominant Aβ species in the native soluble protein fraction of the AD brain

  2012cited by this paper
• Dysfunctional Pro-Ceramide, ER Stress, and Insulin/IGF Signaling Networks with Progression of Alzheimer's Disease

  2012cited by this paper
• Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.

  2012cited by this paper
• Permissive Role of Insulin in the Expression of Long-Term Potentiation in the Hippocampus of Immature Rats

  2011cited by this paper
• A guide to super-resolution fluorescence microscopy

  2010influential reference
• Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration.

  2010cited by this paper
• Insulin Levels are Decreased in the Cerebrospinal Fluid of Women with Prodomal Alzheimer's Disease

  2010influential reference
• Neprilysin and Insulin-Degrading Enzyme Levels Are Increased in Alzheimer Disease in Relation to Disease Severity

  2009cited by this paper
• Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease.

  2009cited by this paper
• Insulin Receptor Dysfunction Impairs Cellular Clearance of Neurotoxic Oligomeric Aβ*

  2009cited by this paper
• Argyrophilic grain disease.

  2008cited by this paper
• Amyloid Oligomer Conformation in a Group of Natively Folded Proteins

  2008cited by this paper
• Alzheimer's Disease is Type 3 Diabetes—Evidence Reviewed

  2008cited by this paper
• Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo.

  2008cited by this paper
• Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model.

  2007cited by this paper
• Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology

  2007cited by this paper
• Tau kinases and phosphatases

  2007cited by this paper
• Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies

  2006cited by this paper
• Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?

  2005cited by this paper
• Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: Link to brain reductions in acetylcholine

  2005cited by this paper
• Diabetes mellitus and risk of dementia in the Kungsholmen project

  2004cited by this paper
• O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.

  2004cited by this paper
• Hyperinsulinemia and risk of Alzheimer disease

  2004cited by this paper
• Insulin-Degrading Enzyme as a Downstream Target of Insulin Receptor Signaling Cascade: Implications for Alzheimer's Disease Intervention

  2004cited by this paper
• Role for neuronal insulin resistance in neurodegenerative diseases.

  2004cited by this paper
• Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele.

  2003cited by this paper
• Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo

  2003cited by this paper
• Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.

  2003cited by this paper
• Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis

  2003cited by this paper
• Reduced Hippocampal Insulin-Degrading Enzyme in Late-Onset Alzheimer's Disease Is Associated with the Apolipoprotein E-ε4 Allele

  2003cited by this paper
• Formation of aberrant phosphotau fibrillar polymers in neural cultured cells.

  2002cited by this paper
• Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.

  2001cited by this paper
• Insulin promotes rapid delivery of N-methyl-d- aspartate receptors to the cell surface by exocytosis

  2001cited by this paper
• Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice.

  2001cited by this paper
• Surpassing the lateral resolution limit by a factor of two using structured illumination microscopy

  2000cited by this paper
• Distinct molecular mechanisms and divergent endocytotic pathways of AMPA receptor internalization

  2000cited by this paper
• Evolution of the neuropathology of Alzheimer's disease

  1996cited by this paper
• Insulin gene expression and insulin synthesis in mammalian neuronal cells.

  1994cited by this paper
• The box plot: a simple visual method to interpret data.

  1989cited by this paper

• Soluble and plaque amyloid associations with peripheral glucose dysregulation modulated by tau pathology in Alzheimer’s disease

  2026cites this paper
• Insulin Signaling in Alzheimer’s Disease: Association with Brain Insulin Resistance

  2026cites this paper
• The promise of GLP-1 receptor agonists for neurodegenerative diseases

  2026cites this paper
• Advances in eye-brain axis: anatomy, immunity, and association with visual dysfunction.

  2025cites this paper
• Spatially constrained disulfide bond shuffling delays insulin aggregation and enhances neurotoxicity

  2025cites this paper
• Unravelling the Alzheimer's pathogenesis: Molecular and cellular pathways to neurodegeneration and therapeutic targets.

  2025cites this paper
• DEAD‐Box Helicase 6 Blockade in Brain‐Derived Aβ Oligomers From Alzheimer's Disease Patients Attenuates Neurotoxicity

  2025cites this paper
• Value of blood neural cell-derived small extracellular vesicles in the diagnosis and prediction of Alzheimer's disease: A systematic review

  2025cites this paper
• Cytosolic phospholipase A2 links tau pathology to insulin signaling impairment in Alzheimer’s disease

  2025cites this paper
• Brain Insulin Resistance as an early target to attenuate neuroinflammation, oxidative stress and proteinopathies in Alzheimer’s Disease: A systematic review of five Natural Products

  2025cites this paper
• Protocol for a double-blind placebo-controlled randomised controlled trial assessing the impact of oral semaglutide in amyloid positivity (ISAP) in community dwelling UK adults

  2024cites this paper
• The gut-brain-metabolic axis: exploring the role of microbiota in insulin resistance and cognitive function

  2024cites this paper
• Exploring complexities of Alzheimer's disease: New insights into molecular and cellular mechanisms of neurodegeneration and targeted therapeutic interventions.

  2024cites this paper
• Zeaxanthin and Lutein Ameliorate Alzheimer’s Disease-like Pathology: Modulation of Insulin Resistance, Neuroinflammation, and Acetylcholinesterase Activity in an Amyloid-β Rat Model

  2024cites this paper
• Alzheimer's disease approaches - Focusing on pathology, biomarkers and clinical trial candidates.

  2024cites this paper
• Retracted Article: The interaction between insulin resistance and Alzheimer’s disease: a review article

  2024cites this paper
• Beneficial Effects of Echinacoside on Cognitive Impairment and Diabetes in Type 2 Diabetic db/db Mice

  2024cites this paper
• Long-term use of metformin and Alzheimer’s disease: beneficial or detrimental effects

  2023cites this paper
• Tau in the pancreas: understanding the link between type 2 diabetes mellitus and Alzheimer’s disease

  2023cites this paper
• Triglyceride-glucose index as a valuable predictor for aged 65-years and above in critical delirium patients: evidence from a multi-center study

  2023cites this paper
• Targeting immunometabolic pathways for combination therapy in Alzheimer's disease

  2023cites this paper
• Tau suppresses microtubule-regulated pancreatic insulin secretion

  2023cites this paper
• The Effects of CYP27A1 and CYP7B1 on cognitive function: two mouse models in Comparison

  2023cites this paper
• Different effects of CYP27A1 and CYP7B1 on cognitive function: Two mouse models in comparison

  2023cites this paper
• The Deficits of Insulin Signal in Alzheimer’s Disease and the Mechanisms of Vanadium Compounds in Curing AD

  2023cites this paper
• The retina-brain axis and diabetic retinopathy

  2023influential citation
• The potential role of human islet amyloid polypeptide in type 2 diabetes mellitus and Alzheimer’s diseases

  2023cites this paper
• Targeting Neuroinflammation as Disease Modifying Approach to Alzheimer's Disease: Potential and Challenges.

  2023cites this paper
• Probiotic supplement as a promising strategy in early tau pathology prevention: Focusing on GSK-3β?

  2023cites this paper
• Hippocampal GFAP-positive astrocyte responses to amyloid and tau pathologies

  2023cites this paper
• The relationship of insulin resistance and diabetes to tau PET SUVR in middle-aged to older adults

  2023cites this paper
• Serum Thioredoxin-80 is associated with age, ApoE4, and neuropathological biomarkers in Alzheimer’s disease: a potential early sign of AD

  2022cites this paper
• The Strategies for Treating “Alzheimer’s Disease”: Insulin Signaling May Be a Feasible Target

  2022cites this paper
• Linking Diabetes to Alzheimer’s Disease: Potential Roles of Glucose Metabolism and Alpha-Glucosidase

  2022cites this paper
• Potential mechanisms to modify impaired glucose metabolism in neurodegenerative disorders

  2022cites this paper
• Incretin-based drugs as potential therapy for neurodegenerative diseases: Current status and perspectives.

  2022cites this paper
• Emerging blood exosome-based biomarkers for preclinical and clinical Alzheimer’s disease: a meta-analysis and systematic review

  2022cites this paper
• Neuron-derived Thioredoxin-80: a novel regulator of type-I interferon response in microglia

  2022cites this paper
• The role of melatonin in the treatment of type 2 diabetes mellitus and Alzheimer's disease

  2022cites this paper
• Insulin and Insulin Resistance in Alzheimer’s Disease

  2021cites this paper
• Therapies for Alzheimer's disease: a metabolic perspective.

  2021cites this paper
• A Tau-Driven Adverse Outcome Pathway Blueprint Toward Memory Loss in Sporadic (Late-Onset) Alzheimer’s Disease with Plausible Molecular Initiating Event Plug-Ins for Environmental Neurotoxicants

  2021cites this paper
• Insulin resistance is related to cognitive decline but not change in CSF biomarkers of Alzheimer's disease in non‐demented adults

  2021cites this paper
• Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer’s Disease Treatment

  2021cites this paper
• The Link Between Diabetes Mellitus and Tau Hyperphosphorylation: Implications for Risk of Alzheimer's Disease

  2021cites this paper
• Dementias Caused by Persistent Pathogens and the Protective Role of HLA Against them

  2020cites this paper
• Revealing lipid droplets evolution at nanoscale under proteohormone stimulation by a BODIPY- hexylcarbazole derivative.

  2020cites this paper
• Putative Involvement of Endocrine Disruptors in the Alzheimer's Disease Via the Insulin-Regulated Aminopeptidase/GLUT4 Pathway

  2020cites this paper
• Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review

  2020cites this paper
• Oxidatively Modified Proteins: Cause and Control of Diseases

  2020cites this paper
• Neuronal insulin signaling and brain structure in nondemented older adults: the Atherosclerosis Risk in Communities Study.

  2020cites this paper
• Toward refining Alzheimer's disease into overlapping subgroups

  2020cites this paper
• Neuronal insulin signaling and brain structure in non-demented older adults: The ARIC Study

  2020cites this paper
• Insulin activates microglia and increases COX-2/IL-1β expression in young but not in aged hippocampus.

  2020cites this paper
• The Interplay between Diabetes and Alzheimer’s Disease—In the Hunt for Biomarkers

  2020cites this paper
• Type 2 Diabetes Mellitus: A Risk Factor for Alzheimer’s Disease

  2020cites this paper
• Central and Peripheral Metabolic Defects Contribute to the Pathogenesis of Alzheimer's Disease: Targeting Mitochondria for Diagnosis and Prevention

  2020cites this paper
• Insulin resistance and impaired lipid metabolism as a potential link between diabetes and Alzheimer's disease

  2020cites this paper
• Understanding the link between insulin resistance and Alzheimer's disease: Insights from animal models

  2019cites this paper
• Effect of nutrition on neurodegenerative diseases. A systematic review

  2019cites this paper
• Restoring synaptic function through multimodal therapeutics.

  2019cites this paper
• Insulin-Mediated Changes in Tau Hyperphosphorylation and Autophagy in a Drosophila Model of Tauopathy and Neuroblastoma Cells

  2019cites this paper
• Targeting the Synapse in Alzheimer’s Disease

  2019cites this paper
• Experimental Neurology

  2019cites this paper
• Association of Extracellular Vesicle Biomarkers With Alzheimer Disease in the Baltimore Longitudinal Study of Aging.

  2019cites this paper
• Current and emerging avenues for Alzheimer's disease drug targets

  2019cites this paper
• Alzheimer's Disease: key developments support promising perspectives for therapy.

  2019cites this paper
• Iron Deposition Leads to Hyperphosphorylation of Tau and Disruption of Insulin Signaling

  2019cites this paper
• Role of the Blood-Brain Barrier in Central Nervous System Insulin Resistance

  2019cites this paper
• A New Vision for Therapeutic Hypothermia in the Era of Targeted Temperature Management: A Speculative Synthesis

  2019cites this paper
• Cross-disease analysis of Alzheimer’s disease and type-2 Diabetes highlights the role of autophagy in the pathophysiology of two highly comorbid diseases

  2019cites this paper
• The Link Between Tau and Insulin Signaling: Implications for Alzheimer’s Disease and Other Tauopathies

  2019cites this paper
• Brain insulin response and peripheral metabolic changes in a Tau transgenic mouse model.

  2019cites this paper
• A pathogenic tau fragment compromises microtubules, disrupts insulin signaling and induces the unfolded protein response

  2019cites this paper
• The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer’s Dementia

  2019cites this paper
• KCa3.1 deficiency attenuates neuroinflammation by regulating an astrocyte phenotype switch involving the PI3K/AKT/GSK3β pathway.

  2019cites this paper
• Identifying key genes, pathways and screening therapeutic agents for manganese-induced Alzheimer disease using bioinformatics analysis

  2018cites this paper
• Evidence for altered insulin receptor signaling in Alzheimer's disease

  2018cites this paper
• Ginkgo biloba Extract EGb 761 and Its Specific Components Elicit Protective Protein Clearance Through the Autophagy-Lysosomal Pathway in Tau-Transgenic Mice and Cultured Neurons

  2018cites this paper
• Alzheimer's Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological Traits

  2018cites this paper
• The Implication of the Brain Insulin Receptor in Late Onset Alzheimer’s Disease Dementia

  2018cites this paper
• Mutual Relationship between Tau and Central Insulin Signalling: Consequences for AD and Tauopathies?

  2018cites this paper
• Are Tanycytes the Missing Link Between Type 2 Diabetes and Alzheimer’s Disease?

  2018cites this paper
• Brain insulin signalling, glucose metabolism and females' reproductive aging: A dangerous triad in Alzheimer's disease

  2018influential citation
• Pathogenic Feed-Forward Mechanisms in Alzheimer’s and Parkinson’s Disease Converge on GSK-3

  2018cites this paper
• Amyloid, tau, pathogen infection and antimicrobial protection in Alzheimer’s disease –conformist, nonconformist, and realistic prospects for AD pathogenesis

  2018cites this paper
• Alzheimer's disease (AD) therapeutics – 1: Repeated clinical failures continue to question the amyloid hypothesis of AD and the current understanding of AD causality

  2018cites this paper
• Alzheimer disease: Is p-tau the missing link between insulin resistance and AD?

  2017cites this paper
• World Journal of Diabetes

  year unknowncites this paper
• Negative correlation between microRNA and insulin sensitivity gene expression in adipose tissue: potential implications for diabetes and neurodegenerative diseases

  year unknowncites this paper